Skip to main content
. 2022 Feb 25;14(3):507. doi: 10.3390/pharmaceutics14030507

Table 3.

ANOVA of best fitted designing model for vesicle size (Y1) and entrapment efficiency (Y2).

Vesicle Size (VS)
Source Sum of Squares Mean Square F-Value p-Value Prob > F Remark
Model (2nd order) 74,666.22 18,666.55 646.03 <0.0001 Significant
A-CHO 29,058.51 29,058.51 1005.69 <0.0001 --
B-Lipid 30,284.67 30,284.67 1048.13 <0.0001 --
C-Surfactant 11,128.26 11,128.26 385.14 <0.0001 --
D-Bile salt 4194.78 4194.784 145.17 <0.0001 --
Residual 635.66 28.89394 -- -- --
Lack of Fit 631.00 31.55001 13.52 0.0710 NS
Pure Error 4.66 2.333333 -- -- --
Total 75,301.89 -- -- -- --
Entrapment efficiency (EE)
Model 3599.88 359.98 36.53 <0.0001 Significant
A-CHO 1779.01 1779.01 180.54 <0.0001 --
B-Lipid 778.43 778.43 79.00 <0.0001 --
C-Surfactant 544.05 544.05 55.21 <0.0001 --
D-Bile salt 239.41 239.41 24.29 0.0002 --
AB 110.25 110.25 11.18 0.0041 --
AC 0.66 0.66 0.06 0.7985 --
AD 6.25 6.25 0.63 0.4374 --
BC 1.22 1.22 0.12 0.7294 --
BD 91.58 91.58 9.29 0.0077 --
CD 49 49 4.97 0.0404 --
Residual 157.65 9.85 -- -- --
Lack of Fit 155.44 11.10 10.04 0.0942 NS
Pure Error 2.21 1.105 -- -- --
Total 3757.54 -- -- -- --